Testing effectiveness (Phase 2)Study completedNCT00174343What this trial is testingExemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer PatientsWho this might be right forBreast Neoplasms Pfizer 46
Early research (Phase 1)Not Yet RecruitingNCT06015568What this trial is testingStudy of MCLA-129 Combined With Befotertinib in the Treatment of Advanced Non-small Cell Lung Cancer With EGFR Sensitive MutationWho this might be right forNon-Small Cell Lung Cancer、EGFR Sensitive Mutation Betta Pharmaceuticals Co., Ltd. 172
Early research (Phase 1)Study completedNCT03087591What this trial is testingAPN401 in Treating Patients With Recurrent or Metastatic Pancreatic Cancer, Colorectal Cancer, or Other Solid Tumors That Cannot Be Removed by SurgeryWho this might be right forMetastatic Malignant Neoplasm in the BrainMetastatic Solid NeoplasmRecurrent Colorectal Carcinoma+9 more Wake Forest University Health Sciences 11
Testing effectiveness (Phase 2)Study completedNCT04200482What this trial is testingLifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer SurvivorsWho this might be right forAnatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8+19 more Fred Hutchinson Cancer Center 90
Not applicableStudy completedNCT03029182What this trial is testingSimulated-altitude to Optimize Aerobic Exercise Among Breast Cancer Survivors With Limited MobilityWho this might be right forObesityBreast Cancer University of Alabama at Birmingham 15
Not applicableActive Not RecruitingNCT06291324What this trial is testingWATD and Cancer-Related Fatigue: A Study For Patients Undergoing Anti-Cancer TreatmentWho this might be right forPancreatic CancerBreast Cancer Wake Forest University Health Sciences 46
Not applicableWithdrawnNCT00908739What this trial is testingStudying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney CancerWho this might be right forKidney Cancer Case Comprehensive Cancer Center
Not applicableLooking for participantsNCT06587100What this trial is testingWearable Activity Tracking to Curb HospitalizationsWho this might be right forHematopoietic NeoplasmMalignant Solid NeoplasmLymphatic System Neoplasm University of California, San Francisco 260
Early research (Phase 1)Looking for participantsNCT07347418What this trial is testingCD64 CAR T Cell Therapy in Adults With Relapsed and/or Refractory AMLWho this might be right forRefractory Acute Myeloid Leukemia (AML)Relapsed Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome+1 more University of Colorado, Denver 23
Not applicableStudy completedNCT04179890What this trial is testingThe Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by OsimertinibWho this might be right forNon-squamous, Non-Small Cell Lung Cancer Boehringer Ingelheim 462
Not applicableStudy completedNCT00902213What this trial is testingPhysical Activity to Modify Sequelae and Quality of Life in Childhood Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia St. Jude Children's Research Hospital 122
Not applicableStudy completedNCT03190720What this trial is testingDevelopment of Exercise Promotion Program Using a Mobile CommunityWho this might be right forBreast CancerPhysical Activity Asan Medical Center 64
Post-approval studies (Phase 4)Study completedNCT03449758What this trial is testingEffect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Sanofi 84
Testing effectiveness (Phase 2)Study completedNCT00080015What this trial is testingDiflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC)Who this might be right forSmall Cell Lung Cancer Ipsen 9
Not applicableStudy completedNCT01896713What this trial is testingThe Value of MultiSpectral 3 Tesla MRI in Active Surveillance of Prostate CancerWho this might be right forProstate Cancer Sunnybrook Health Sciences Centre 81
Early research (Phase 1)Looking for participantsNCT07755397What this trial is testingFirst in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands TumorWho this might be right forNSCLC Patients With EGFR Activating MutationAdenoid Cystic Carcinoma MetastaticAdenoid Cystic Carcinoma of the Head and Neck Jubilant Therapeutics India Limited 30
Not applicableNot Yet RecruitingNCT07365618What this trial is testingCombined Exercise Effects in Breast Cancer-related LymphedemaWho this might be right forBreast Cancer-Related Lymphedema Faculdade de Motricidade Humana 58
Large-scale testing (Phase 3)Active Not RecruitingNCT06077760What this trial is testingIntismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)Who this might be right forNon-small Cell Lung Cancer Merck Sharp & Dohme LLC 868
Testing effectiveness (Phase 2)Looking for participantsNCT05607420What this trial is testingStudy Evaluating UCART20x22 in B-Cell Non-Hodgkin LymphomaWho this might be right forB-cell Non-Hodgkin Lymphoma (B-NHL) Cellectis S.A. 80
Not applicableUnknownNCT05257785What this trial is testingLymfit to Improve the Fitness and Quality of Life in Lymphoma SurvivorsWho this might be right forLymphomaCancer Survivors McGill University 50